Effects of Moderate Physical Activity on Glycemic Control in Type 2 Diabetes Mellitus

Not Applicable

Completed

• Conditions: Type 2 Diabetes Mellitus

• Registration Number: NCT04924777
• Lead Sponsor: Riphah International University

Brief Summary

The study design is to determine the effectiveness of moderate physical activity on g;lycemic control in type 2 diabetes mellitus.

Detailed Description

To the best of authors knowledge so far the studies have been conducted on different modes of moderate physical activity on glycemic control in type 2 diabetes, current study goal is to evaluate which mode of moderate physical activity has more significant result on glycemic control in type 2 diabetes and is sustainable in Pakistani society according to the socioeconomic status and cost effectiveness of the modes of moderate physical activity.

Study Timeline

• Study Start: 2021-04-01
• Study First Submitted: 2021-06-11
• Study First Submitted QC: 2021-06-11
• Study First Posted: 2021-06-14
• Primary Completion: 2021-07-31
• Study Completion: 2021-07-31
• Status Verified: 2021-11
• Last Update Submitted: 2021-11-24
• Last Update Posted: 2021-11-26

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 48

Inclusion Criteria

• Participants falling in this category would be recruited into the study.
• Male/female
• Diabetic type 2 patients
• Age: 30-70 years
• BMI >25
• Overweight
• Fat % in male> 25
• Fat % in female >35
• HbA1c level more than 48mmol/mol or >6.5%
• Fasting Plasma Glucose level >126 mg/dl (7.0 mmol/l)
• Random Plasma glucose level >200 mg/dl (11.1 mmol/l)
• Physically active ( have no mobility problems)

Exclusion Criteria

• Participant failing to fall in this category would be excluded of the study.
• Type 1 diabetes
• Insulin dependant type 2 diabetes
• Gestational Diabetes
• Hypertension
• Cigarette smoking
• Cardiovascular Disease
• Cerebrovascular disease
• Cardiopulmonary Disorders
• Cognition Problems
• Peripheral Artery Disease
• Dyslipidemia
• Proliferative or preproliferative retinopathy
• Nephropathy
• Neuropathy

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
HbA1c Levels	3 months	Reduction in HbA1c levels

Trial Locations

Locations (1)

Riphah Rehabilitation Center; 🇵🇰 Islamabad, Pakistan